Early infantile epileptic encephalopathy associated with a high voltage gated calcium channelopathy

Simon Edvardson1, Shimrit Oz, Fida Aziz Abulhijaa

  • 1The Monique and Jacques Roboh Department of Genetic Research, Hadassah, Hebrew University Medical Center, Jerusalem, Israel.

Insights

A CACNA2D2 gene mutation causes infantile epilepsy by disrupting neuronal calcium channel function. This study identifies a novel genetic cause for early infantile epileptic encephalopathy, highlighting the role of auxiliary calcium channel subunits.

Area of Science:

  • Neurogenetics
  • Ion Channel Physiology
  • Molecular Neuroscience

Background:

  • Early infantile epileptic encephalopathies (EIEE) are severe developmental disorders often linked to genetic mutations.
  • Ion channelopathies, particularly those affecting calcium channels, are significant contributors to EIEE.
  • Investigating genetic causes in affected siblings is crucial for understanding EIEE pathogenesis.

Observation:

  • A homozygous mutation (p.L1040P) in the CACNA2D2 gene was identified in three siblings with infantile epilepsy.
  • The CACNA2D2 gene encodes the auxiliary α(2)δ2 subunit of high voltage-gated calcium channels.
  • The identified mutation affects the function and expression of specific calcium channel subtypes.

Findings:

  • The p.L1040P mutation in CACNA2D2 leads to reduced current density and impaired inactivation of neuronal calcium channels (Ca(V)2.2 and Ca(V)1.2).
  • Mutant α(2)δ2-L1040P does not facilitate the plasma membrane expression of the Ca(V)2.2 α(1B) subunit, unlike wild-type α(2)δ2.
  • This dysfunction in calcium channel regulation is directly linked to the observed epileptic phenotype.

Implications:

  • This is the first report of an encephalopathy caused by a mutation in the auxiliary α(2)δ subunit of human high voltage-gated calcium channels.
  • The findings underscore the critical role of the α(2)δ2 subunit in human brain physiology and neuronal excitability.
  • Understanding these molecular mechanisms opens new avenues for diagnosing and potentially treating infantile epilepsy.
Abstract

Related Concept Videos

Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...